Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03198663
Other study ID # R01MH104106
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2016
Est. completion date April 1, 2020

Study information

Verified date June 2023
Source Cook County Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Black young men who have sex with men (BYMSM) are at high risk for contracting and transmitting HIV, and represent a priority population for developing effective interventions. Within the House Ball community (HBC), a clandestine subculture of the Black gay community, HIV is highly stigmatized. This stigma, coupled with high HIV prevalence rates and elevated levels of undiagnosed/untreated HIV infection, places BYMSM in HBCs at incredible risk for HIV infection. Community-level interventions that target social norms, behavior, and stigma in the HBC are sorely needed in order to make a broader impact among BYMSM. Building on prior work in the community, this study proposes to launch an innovative Effectiveness-Implementation Hybrid Type 2 trial to examine the effectiveness and implementation of a community-level HIV prevention intervention (called POSSE) based on popular opinion leader (POL) models across two cities with similar HBCs, Chicago and Philadelphia. The proposed study has two specific aims: 1) To determine the effectiveness of a POL intervention, POSSE, to decrease sexual risk behavior (UAI), STIs and HIV stigma among BYMSM in the HBC; and 2) To evaluate the processes, strategies, barriers and facilitators for the implementation of POSSE delivered across two distinct metropolitan areas with high HIV prevalence among BYMSM and similar House Ball Communities. To examine these aims, the investigators will first use social network strategies to identify, screen, and recruit POLs (n=75) from the Philadelphia HBC. The investigators will then gather baseline behavioral and biological (HIV/STI testing) data in both Chicago and Philadelphia (n=100 BYMSM per city) and train the Philadelphia POLs to implement the POSSE intervention. The investigators will conduct an implementation-focused process evaluation to assess fidelity to the POSSE intervention; number, content, spread, and acceptability of risk reduction messages; age appropriateness of the messages; acceptability of the overall intervention; and barriers/facilitators to implementation. Next, the investigators will complete follow-up assessments every 6 months post- intervention in both cities (n=100 BYMSM per city at each assessment point). The investigators will also assess behavior change in those delivering the intervention (POLs) at each assessment point. The investigators will conduct implementation-focused qualitative interviews with POLs (n=15) and community participants (n=30) from Philadelphia. Last, the investigators will implement POSSE in Chicago by repeating the steps outlined above, continuing assessments in both cities, and conducting qualitative interviews in Chicago.


Recruitment information / eligibility

Status Completed
Enrollment 1037
Est. completion date April 1, 2020
Est. primary completion date March 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 15 Years to 25 Years
Eligibility Inclusion Criteria: - self-identified as Black, - between the ages of 15 - 24 (inclusive), and - in attendance at a HBC event at the time of the assessment. Exclusion Criteria: - intoxicated or otherwise unable to consent at time of enrollment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
POSSE
Popular-opinion leader

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cook County Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary HIV incidence 24 months
Secondary STI incidence 24 months
See also
  Status Clinical Trial Phase
Completed NCT03063385 - Puerto Rico Cuidalos Parent-adolescent Program N/A
Active, not recruiting NCT04283929 - Evaluation of Clinical Impacts and Costs of eHealth in Rwanda N/A
Withdrawn NCT03938077 - A Community-University Approach to Preventing HIV N/A
Completed NCT02316444 - Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda Phase 4
Recruiting NCT04319367 - A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs). Phase 2
Completed NCT03368456 - Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention N/A
Recruiting NCT04135443 - Evaluation of 3T, a Sex-Positive HIV/STI Mobile App Intervention for Young Black Men Ages 14-19 Attracted to Men N/A
Completed NCT03404297 - Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya N/A
Completed NCT03445351 - Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS N/A
Completed NCT03252483 - Integrating HIV and Hepatitis C Screening in an Urban Emergency Department N/A
Completed NCT02712801 - Antiretroviral Regime for Viral Eradication in Newborns Phase 4
Completed NCT02406482 - Evaluating a Microfinance Intervention for Vulnerable Women in Kazakhstan N/A
Recruiting NCT04788784 - Patient-Reported Outcomes HIV BItherapy
Recruiting NCT05300035 - Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control Phase 2